CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

"CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer"
written by Samia M. O’Bryan, J. Michael Mathis,
published by Journal of Cancer Therapy, Vol.12 No.6, 2021

has been cited by the following article(s):

[1]	Oncolytic virus-based combination therapy in breast cancer
	Cancer Letters, 2024

[2]	Construction and application of adenoviral vectors
	Molecular Therapy. Nucleic …, 2023

[3]	Evaluation of the influence of the CXC motif chemokine ligand 12/CXC chemokine receptor 4 axis on canine mammary gland tumor cell migration
	Journal of Veterinary …, 2023

[4]	Phage‐Derived Oncolytic Viruses with 3C from Seneca Valley Virus for Targeted Therapy of Cervical Cancer
	Advanced …, 2022

[5]	Adenovirus oncolítico como estrategia de tratamiento en cáncer de seno

[1]	Oncolytic virus-based combination therapy in breast cancer Cancer Letters, 2024 DOI:10.1016/j.canlet.2024.216634

[2]	The investigation of oncolytic viruses in the field of cancer therapy Frontiers in Oncology, 2024 DOI:10.3389/fonc.2024.1423143

[3]	Evaluation of the influence of the C-X-C motif chemokine ligand 12 / C-X-C chemokine receptor 4 axis on canine mammary gland tumor cell migration Journal of Veterinary Medical Science, 2023 DOI:10.1292/jvms.23-0126

[4]	Construction and application of adenoviral vectors Molecular Therapy - Nucleic Acids, 2023 DOI:10.1016/j.omtn.2023.09.004

[5]	Phage‐Derived Oncolytic Viruses with 3C from Seneca Valley Virus for Targeted Therapy of Cervical Cancer Advanced Therapeutics, 2022 DOI:10.1002/adtp.202200059

Follow SCIRP